Patient recruitment is one of the most critical foundations of any…
Category: Clinical Trials
Home / Clinical Trials /
QPS has been assisting an international Sponsor to perform a global,…
QPS has been assisting an international Sponsor to perform a global,…
The European Medicines Agency (EMA) has released a draft guideline revision…
Making the right decision about where to conduct Phase I of…
Okay, we’ll admit it: a company telling you about their new…
QPS was able to deliver on this extremely challenging early phase…
The sheer abundance of diet drugs available suggests two things: 1)…
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
Webinars
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
May 4, 2016
Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success if
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational drug
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are fulfilled,
Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients
August 18, 2015
Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures –
First-in-Human, Safety, Tolerability, PK and PD Study of a Rapid Onset Anesthetic: QPS Plays It Safe!
August 28, 2015
QPS was able to deliver on this extremely challenging early phase clinical trial because we have access to the expertise of a university anaesthesiology department
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work significantly
Regulatory Expertise Now Part of QPS Clinical Development Offerings
July 9, 2015
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory aspects
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
